65,437 trials
Influenza
Primary: Number of Participants Reporting Solicited Subjective Local Reactions After First Vaccination — 15; 21; 26; 37 Participants
Colorectal Cancer
Primary: Disease Control Rate (DCR) and Objective Response Rate (ORR) According to the Response Evaluation Criteria in Solid Tumors (RECIST) — 31.0; 32.4; 0; 0 Percentage of…
Acute Gout
Primary: The Dose of Canakinumab for Treatment of Acute Flares in Gout Patients That Leads to the Same Efficacy as Triamcinolone Acetonide With Respect to Pain Intensity on a…
Allergic Asthma
Primary: Number of Participants With Systemic Allergic Reactions (SAR) to Specific Immunotherapy (SIT) — 32; 17; 49 participants
Cerebral Infarction
Primary: Numbers of Patients With First Occurence of Stroke — 82; 119 participants — p=0.0357
Non Therapeutic Body Modification
Primary: Safety Endpoint — 155; 0; 3 Participants
Diabetes · Diabetes Mellitus, Type 2
Primary: Mean Change From Randomisation in Glycosylated Haemoglobin A1c (HbA1c) at Week 26. — 0.02; -0.51 Percentage point of total HbA1c
Acute Myelogenous Leukemia · Myelodysplastic Syndrome
Primary: Number of Participants With Invasive Fungal Infection — 3; 4; 2 participants
Contraception
Primary: Area Under the Curve (AUC) From Time 0 to 24 Weeks [AUC(0-24weeks)] for Plasma Folate and RBC (Red Blood Cell) Folate (Baseline Uncorrected) — 1030; 904; 24176; 21876…
Multiple Myeloma
Primary: Number of Subjects Treated With (HD DTPACE Obtain a Complete Response or Near Complete Response That Lasts for 6 Months or Longer. — 0 participant response
Diabetes · Diabetes Mellitus, Type 1
Primary: Change From Baseline in Insulin Detemir - Human Insulin Cross-reacting Antibodies — 1.81; 1.89 ratio — p=0.649
Ulcerative Colitis
Primary: Percentage of Patients Remaining in Remission at Month 6, ITT Population, Determined by the Simple Clinical Colitis Activity Index (SCCAI) — 90.5; 91.8 Percentage of…
Vaccines · Pneumococcal Conjugate Vaccine
Primary: Percentage of Participants Achieving a Predefined Antibody Level of Greater Than or Equal to 0.35 Micrograms (mcg)/mL, 1 Month After the Infant Series. — 98.8; 100.0…
Leukemia · Fungal Infection
Primary: Percentage of Samples With BG Levels > 60pg/ml — 4; 5; 3; 3 percent of blood samples
Coronary Disease · Cardiovascular Diseases · Heart Diseases
Primary: Number of Participants With All-Cause Mortality — 80; 75; 80; 81 participants — p=0.97